Anew Medical, Inc.
WENA · NASDAQ
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $396 | $325 | $348 | $259 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $18 | -$23 | -$33 |
| Operating Expenses | $396 | $343 | $325 | $292 |
| Operating Income | -$396 | -$343 | -$325 | -$292 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$56 | $269 | $526 | $731 |
| Pre-Tax Income | -$452 | -$74 | $201 | $439 |
| Tax Expense | $0 | $49 | $112 | $149 |
| Net Income | -$452 | -$123 | $89 | $290 |
| % Margin | – | – | – | – |
| EPS | -0.03 | -0.024 | 0.017 | 0.033 |
| % Growth | -25.5% | -239% | -47.9% | – |
| EPS Diluted | -0.03 | -0.024 | 0.017 | 0.033 |
| Weighted Avg Shares Out | 15,055 | 5,165 | 5,165 | 8,802 |
| Weighted Avg Shares Out Dil | 15,055 | 5,165 | 5,165 | 8,802 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $252 | $510 | $742 |
| Interest Expense | $15 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$396 | -$343 | -$325 | -$292 |
| % Margin | – | – | – | – |